Efficacy of combined angiotensin II receptor blocker with tripterygium glycosides on diabetic nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of combined angiotensin II receptor blocker with tripterygium glycosides on diabetic nephropathy

Published:2021-06-04 Issue:22 Volume:100 Page:e25991
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Ma Chang-e,Yu Pei,Wei Wei,Chen Xiao-qin

Funder

Innovation Fund Project for Institutions of Higher Education in Gansu Province

Gansu Natural Science Foundation Project

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference14 articles.

1. Protective role of Nigella sativa in diabetic nephropathy: a randomized clinical trial;Ansari;Saudi J Kidney Dis Transpl,2017

2. Efficacy and safety of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in hemodialysis patients with diabetic nephropathy: a randomized open-label prospective trial;Abe;Diabetes Res Clin Pract,2016

3. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030;Whiting;Diabetes Res Clin Pract,2011

4. Dialysis: a review of the mechanisms underlying complications in the management of chronic renal failure;Vadakedath;Cureus,2017

5. Effectiveness comparisons of traditional Chinese medicine on treating diabetic nephropathy proteinuria: a systematic review and meta-analysis;Wang;Medicine (Baltimore),2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new perspective on proteinuria and drug therapy for diabetic kidney disease;Frontiers in Pharmacology;2024-07-31

2. Clinical efficacy and safety of warm acupuncture in the treatment of type 2 diabetic kidney disease: A protocol of a randomized controlled trial;Medicine;2022-12-02

3. Clinical Effects of Primary Nursing on Diabetic Nephropathy Patients Undergoing Hemodialysis and Its Impact on the Inflammatory Responses;Evidence-Based Complementary and Alternative Medicine;2022-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3